The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
Saved in:
| Title: | The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group. |
|---|---|
| Authors: | Papageorgiou SG; Second Department of Internal Medicine and Research Unit, University General Hospital 'Attikon', Athens, Greece., Kontos CK; Department of Biochemistry and Molecular Biology, University of Athens, Athens, Greece., Kotsianidis I; Department of Hematology, Democritus University of Thrace Medical School, University Hospital of Alexandroupolis, Alexandroupolis, Greece.; The Hellenic (Greek) MDS Study Group, Athens, Greece., Vasilatou D; Second Department of Internal Medicine and Research Unit, University General Hospital 'Attikon', Athens, Greece., Symeonidis A; The Hellenic (Greek) MDS Study Group, Athens, Greece.; General University Hospital of Patras, Patras, Greece., Galanopoulos A; The Hellenic (Greek) MDS Study Group, Athens, Greece.; General Hospital of Athens 'G. Gennimatas', Athens, Greece., Bouchla A; Second Department of Internal Medicine and Research Unit, University General Hospital 'Attikon', Athens, Greece., Hatzimichael E; University Hospital of Ioannina, Ioannina, Greece., Repousis P; Department of Hematology, 'Metaxa' Piraeus Cancer Hospital, Piraeus, Greece., Zikos P; General Hospital of Patras 'Agios Andreas', Patras, Greece., Viniou NA; The Hellenic (Greek) MDS Study Group, Athens, Greece.; First Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece., Poulakidas E; '401' Army General Hospital of Athens, Athens, Greece., Vassilakopoulos TP; Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece., Diamantopoulos P; First Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece., Diamantopoulos MA; Department of Biochemistry and Molecular Biology, University of Athens, Athens, Greece., Mparmparousi D; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Bouronikou E; University General Hospital of Larissa, Larissa, Greece., Papadaki H; University General Hospital of Heraklion, Heraklion, Greece., Panayiotidis P; First Propaedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece., Pappa V; Second Department of Internal Medicine and Research Unit, University General Hospital 'Attikon', Athens, Greece.; The Hellenic (Greek) MDS Study Group, Athens, Greece. |
| Source: | Hematological oncology [Hematol Oncol] 2018 Oct; Vol. 36 (4), pp. 693-700. Date of Electronic Publication: 2018 Sep 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1099-1069 |
|---|---|
| DOI: | 10.1002/hon.2551 |
